Screening, Treatment, and Eradication of Hep C

Not yet recruitingOBSERVATIONAL

Enrollment

112,136

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

October 1, 2030

Study Completion Date

December 1, 2030

Conditions

Hepatitis C Virus Infection

Interventions

DIAGNOSTIC_TEST

Hepatitis C Virus Screening

1-2 Blood Screenings for Hepatitis C Virus

All Listed Sponsors

lead

Liver Institute PLLC

OTHER

NCT05071261 - Screening, Treatment, and Eradication of Hep C | Biotech Hunter | Biotech Hunter